LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 63.26 | 27.76 | 8377 | 6465 | 1.2956 | 1.0670 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 63.26 | 27.76 | 8568 | 6465 | 1.3252 | 1.0729 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 63.26 | 27.76 | 7712 | 6465 | 1.1928 | 1.0453 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 63.26 | 27.76 | 7775 | 6465 | 1.2025 | 1.0475 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 64.97 | 27.76 | 8599 | 6656 | 1.2918 | 1.0658 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 64.97 | 27.76 | 8781 | 6656 | 1.3191 | 1.0713 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 64.97 | 27.76 | 7963 | 6656 | 1.1962 | 1.0458 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 64.97 | 27.76 | 8068 | 6656 | 1.2120 | 1.0492 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 66.67 | 27.76 | 8880 | 6695 | 1.3262 | 1.0726 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 66.67 | 27.76 | 9061 | 6695 | 1.3533 | 1.0779 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 66.67 | 27.76 | 8259 | 6695 | 1.2335 | 1.0537 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 66.67 | 27.76 | 8414 | 6695 | 1.2566 | 1.0586 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 68.37 | 27.76 | 9154 | 6879 | 1.3307 | 1.0731 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 68.37 | 27.76 | 9315 | 6879 | 1.3541 | 1.0777 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 68.37 | 27.76 | 8236 | 6879 | 1.1972 | 1.0458 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 68.37 | 27.76 | 8568 | 6879 | 1.2455 | 1.0560 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 70.08 | 27.76 | 9271 | 6849 | 1.3535 | 1.0776 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 70.08 | 27.76 | 9568 | 6849 | 1.3968 | 1.0859 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 70.08 | 27.76 | 7836 | 6849 | 1.1440 | 1.0341 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 70.08 | 27.76 | 8808 | 6849 | 1.2859 | 1.0643 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 71.78 | 27.76 | 9532 | 6893 | 1.3828 | 1.0832 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 71.78 | 27.76 | 9737 | 6893 | 1.4126 | 1.0887 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 71.78 | 27.76 | 7258 | 6893 | 1.0529 | 1.0130 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 71.78 | 27.76 | 8890 | 6893 | 1.2897 | 1.0650 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 73.48 | 27.76 | 9585 | 6957 | 1.3776 | 1.0820 | MN20160318_Q01 | I12 |